Blue-Chip Stocks: The 10 Long-Term Holdings That Built Portfolios
Picking so-called blue chips is one of the most common long-term investing jobs, and the label expires if nobody rechecks it. Here are the three tests, how to hold them, and why GE is the warning.


Choosing blue-chip stocks for a long-term portfolio is one of the most common jobs in investing, not only for people who want something that feels safer than the rest of the market but for anyone who inherited a name their grandparents trusted. The work involves checking a moat, a balance sheet and a boring business from public filings, diversifying across the group rather than three favourites, reinvesting dividends, and re-running the tests once a year so the label does not outlive the company.
On the other hand, a handful of large, durable businesses held for decades can do the slow compounding that actually builds a portfolio. A stock returning 8-10% a year with dividends reinvested doubles roughly every seven to nine years. That is the whole mathematical case, and it needs no timing and no genius. An index fund does the same job for hundreds of companies at once if ten positions is too many to manage.
Here are some things you can do to tell a real blue chip from a name that used to be one.
The three tests
Checkable from any company's public filings on the SEC's EDGAR database: a moat, something structural that protects profits, a brand, a network, scale, so a well-funded competitor should still struggle to displace it in five years. A strong balance sheet, investment-grade credit, real free cash flow, because blue chips borrow cheaper in a crisis, which is when they buy up weaker rivals. And a boring business, predictable, unglamorous ways of making money. Excitement is what you pay for. Boredom is what pays you. Price going up is not one of the tests. Price is the output.
The classic ten, and what the numbers actually show
General Electric was a Dow component for over a century, a dividend payer, the stock grandparents bought for grandchildren. Then its finance arm unravelled, the conglomerate broke apart, and shareholders who trusted the name lost most of what they had built. The label describes today's company, not tomorrow's, and it is why the three tests above are an annual check rather than a badge earned once.
Our live table tracks Apple, Microsoft, JPMorgan Chase, Johnson & Johnson, Coca-Cola, Procter & Gamble, Visa, Walmart, ExxonMobil and Home Depot, ten sectors compressed into ten tickers. Look at ten-year returns and dispersion is enormous, the best can return five to ten times the worst, so safe does not mean equal and it does not mean interchangeable.
View data tableHide data table
| Date | AAPL | MSFT | JNJ | KO | XOM |
|---|---|---|---|---|---|
| Jan 2016 | $10,000 | $10,000 | $10,000 | $10,000 | $10,000 |
| Apr 2016 | $9,630 | $9,052 | $10,732 | $10,438 | $11,355 |
| Jul 2016 | $10,706 | $10,289 | $11,991 | $10,165 | $11,426 |
| Oct 2016 | $11,664 | $10,877 | $11,106 | $9,879 | $10,703 |
| Jan 2017 | $12,467 | $11,735 | $10,844 | $9,685 | $10,776 |
| Apr 2017 | $14,758 | $12,427 | $11,822 | $10,054 | $10,488 |
| Jul 2017 | $15,279 | $13,197 | $12,708 | $10,680 | $10,281 |
| Oct 2017 | $17,366 | $15,099 | $13,348 | $10,713 | $10,706 |
| Jan 2018 | $17,201 | $17,246 | $13,232 | $11,088 | $11,214 |
| Apr 2018 | $16,978 | $16,976 | $12,111 | $10,068 | $9,987 |
| Jul 2018 | $19,549 | $19,256 | $12,689 | $10,864 | $10,470 |
| Oct 2018 | $22,484 | $19,388 | $13,404 | $11,156 | $10,235 |
| Jan 2019 | $17,099 | $18,956 | $12,742 | $11,214 | $9,413 |
| Apr 2019 | $20,615 | $23,707 | $13,520 | $11,431 | $10,312 |
| Jul 2019 | $21,886 | $24,736 | $12,468 | $12,262 | $9,552 |
| Oct 2019 | $25,556 | $26,025 | $12,643 | $12,682 | $8,680 |
| Jan 2020 | $31,797 | $30,900 | $14,254 | $13,607 | $7,979 |
| Apr 2020 | $30,183 | $32,530 | $14,366 | $10,692 | $5,969 |
| Jul 2020 | $43,666 | $37,214 | $13,956 | $11,007 | $5,405 |
| Oct 2020 | $44,734 | $36,753 | $13,128 | $11,198 | $4,190 |
| Jan 2021 | $54,226 | $42,106 | $15,619 | $11,219 | $5,760 |
| Apr 2021 | $54,021 | $45,776 | $15,581 | $12,577 | $7,353 |
| Jul 2021 | $59,938 | $51,717 | $16,488 | $13,288 | $7,395 |
| Oct 2021 | $61,557 | $60,196 | $15,596 | $13,134 | $8,281 |
| Jan 2022 | $71,822 | $56,449 | $16,497 | $14,215 | $9,757 |
| Apr 2022 | $64,783 | $50,376 | $17,279 | $15,054 | $10,951 |
| Jul 2022 | $66,780 | $50,960 | $16,710 | $14,951 | $12,451 |
| Oct 2022 | $63,012 | $42,137 | $16,657 | $13,945 | $14,234 |
| Jan 2023 | $59,293 | $44,983 | $15,647 | $14,287 | $14,902 |
| Apr 2023 | $69,727 | $55,774 | $15,674 | $14,946 | $15,201 |
| Jul 2023 | $80,727 | $60,977 | $16,041 | $14,429 | $13,775 |
| Oct 2023 | $70,175 | $61,374 | $14,203 | $13,162 | $13,597 |
| Jan 2024 | $75,776 | $72,169 | $15,214 | $13,861 | $13,206 |
| Apr 2024 | $69,994 | $70,672 | $13,844 | $14,392 | $15,192 |
| Jul 2024 | $91,260 | $75,939 | $15,114 | $15,550 | $15,233 |
| Oct 2024 | $92,833 | $73,761 | $15,306 | $15,217 | $15,001 |
| Jan 2025 | $96,980 | $75,342 | $14,568 | $14,790 | $13,723 |
| Apr 2025 | $87,323 | $71,748 | $14,966 | $16,904 | $13,568 |
| Jul 2025 | $85,297 | $96,842 | $15,774 | $15,818 | $14,340 |
| Oct 2025 | $111,103 | $93,993 | $18,084 | $16,053 | $14,690 |
| Jan 2026 | $106,628 | $78,107 | $21,759 | $17,430 | $18,163 |
| Apr 2026 | $111,506 | $74,021 | $22,008 | $18,350 | $19,824 |
| Jul 2026 | $126,941 | $84,357 | $24,545 | $20,408 | $19,967 |
| Sep 2026 | $131,486 | $90,706 | $26,353 | $20,520 | $20,484 |
Growth of $10,000 from 2016, monthly closes, price return only. Dividends are not reinvested, so income-paying funds are understated here. Market data to September 2026.
Four rules for actually holding them
1. Diversify across the group rather than your three favourites. Ten blue chips across eight sectors behaves very differently from three you happen to like, and if ten positions is more admin than you want, a broad index fund does the same job at a few basis points.
2. Reinvest dividends automatically. In staples and healthcare especially, most of the long-run return has come from reinvested income rather than price. Taking dividends as cash quietly converts a compounding machine into a modest income stream, a reasonable choice in retirement and an expensive one at forty.
3. Rebalance, but rarely. Left alone for a decade, a ten-stock portfolio quietly becomes a two-stock portfolio plus eight rounding errors, because winners compound. That outcome might be fine, but it should be a decision you made rather than one that happened while you were not looking.
4. Recheck all three tests once a year, on a date you pick. It takes an evening, and it is the entire discipline that separates a blue-chip portfolio from a portfolio of names that used to qualify. GE, IBM and General Motors all failed one of the three tests quietly, years before the market fully repriced them.
What not to do
Do not treat the label as permanent, and do not skip the annual check because a company still "feels" safe. IBM spent much of the 2010s shrinking while paying a dividend, an arrangement that read as income and functioned as slow erosion, and investors who skipped the recheck held on well past the point the tests would have flagged it.
Where this leaves you
Buy steadily, reinvest the dividends, and put one evening a year aside to re-run the three tests on everything you hold. That evening is the entire discipline, and it works precisely because it is dull enough that most people abandon it in year three for something more interesting.
If one of your holdings is failing a test and you are unsure whether it is temporary or structural, that is a good argument to bring to @aspirescapital on Instagram. It is the judgement call the tests cannot make for you.
FAQ
Are blue chips actually safer than the rest of the market? Usually, but not always, and never permanently. GE, IBM and General Motors all wore the label while the thing it described was disappearing underneath them.
Do I need to pick individual blue chips myself? No. A broad index fund holds all ten of the classics and hundreds more, with none of the single-company risk.
How often should I recheck whether a holding still qualifies? Once a year, using the same three tests. It takes an evening and it is the whole discipline.
Not investment advice. Past performance does not guarantee future results. Company examples are historical illustrations, not recommendations.